Skip to Main Content

Paper Details

Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer.
Oncologist
1
2023
Author NameAffiliation
Eric S LanderVanderbilt-Ingram Cancer Center, Vanderbilt University
Eric S LanderVanderbilt-Ingram Cancer Center, Vanderbilt University
  • 1 - 2

Datasets

Release 1.2